The FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention
https://reachmd.com/programs/the-drug-report/the-fda-expands-indication-for-baloxavir-marboxil-to-include-post-exposure-influenza-prevention/12043/
Previously used for acute uncomplicated influenza, baloxavir marboxil has been approved by the FDA for post-exposure influenza prevention.
Curing Blindness: How Researchers are Utilizing Gene Therapy
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/curing-blindness-how-researchers-are-utilizing-gene-therapy/8450/
Dr. Jean Bennett discusses her innovative work and research in curing blindness through gene therapy.
An FDA-Approved Therapeutic Treatment Option for Polymyalgia Rheumatica
https://reachmd.com/programs/medical-industry-feature/an-fda-approved-therapeutic-treatment-option-for-polymyalgia-rheumatica/15248/
Explore the role of a therapeutic treatment option for polymyalgia rheumatica and rheumatoid arthritis, and the clinical data that led to its approval in this replay of a live broadcast.
Unlocking the Potential of HER2-Targeted Therapy: Breakthroughs in NSCLC Therapeutic Approaches
https://reachmd.com/programs/cme/unlocking-the-potential-of-her2-targeted-therapy-breakthroughs-in-nsclc-therapeutic-approaches/16213/
Dr. Helena Yu talks HER2-targeted NSCLC therapy, including FDA-approved ADCs and the importance of patient–clinician alignment in treatment decisions.
Keeping Pace in Lung Cancer - Breaking Barriers: Advances in Treating EGFR Exon 20 Insertions in NSCLC
https://reachmd.com/programs/cme/keeping-pace-in-lung-cancer-breaking-barriers-advances-in-treating-egfr-exon-20-insertions-in-nsclc/16082/
Are you as excited as we are to see how FDA approved targeted therapies can help our patients with NSCLC with EGFR exon 20 insertion mutations?
Assessing the Asthma Management Guideline Updates
https://reachmd.com/programs/the-drug-report/assessing-the-asthma-management-guideline-updates/12063/
How have the guidelines on asthma management changed to meet the needs of asthmatic adolescents and adults?
Experts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
https://reachmd.com/programs/medical-industry-feature/experts-discuss-what-the-titan-trial-means-for-managing-patients-with-mcspc/15126/
Dive into the data from the TITAN study, which evaluated a treatment option for patients with mCSPC.
Time is Brain: Diagnosing and Treating Stroke in the Golden Window
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/time-is-brain-diagnosing-and-treating-stroke-golden-window/8216/
Dr. Michael Mullen overviews the clinical hallmarks and priority treatment consideration for stroke.
JAMA: Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies
https://reachmd.com/programs/Audioabstracts/jama-noninvasive-prenatal-testing-and-incidental-detection-occult-maternal-malignancies/7628/
Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies Diana W. Bianchi, MD; Darya Chudova, PhD; Amy J. Sehnert, MD; Sucheta Bhatt, MD; Kathryn Murray, MS; Tracy L. Prosen, MD; Judy E. Garber, MD; Louise Wilkins-Haug, MD, PhD; Neeta L. Vora, MD; Stephen Warsof, MD; Jam
Targeting HER2 Across Advanced Solid Tumors
https://reachmd.com/programs/cme/targeting-her2-across-advanced-solid-tumors/16282/
New precision therapies are emerging that better target advanced solid tumors with HER2 expression.